ArticleEJHaem2024

HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.

Monique C Minnema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.